Company: NCEL
Filing Date: 2025-03-31
Form Type: 425
Source: 0001213900-25-025889
Chunk: 12

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: 425
Chunk 12
---
 or potentially issuable in the future pursuant
to the Transaction Documents, including all Underlying Shares.

<div align='center'>5</div>

“”
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

“”
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

“”
shall have the meaning ascribed to such term in Section 3.1(h).

“”
means the Preferred Shares, Warrants, the Underlying Shares, and all securities issuable in connection therewith.

“”
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

“”
means the Preferred Shares Common Shares purchased pursuant to the terms of this Agreement.

“”
means the receipt of the approval of the Company’s shareholders for the issuance of the Shares as required under Swiss law.

“”
means the Share Option Plan Regulation 2021 (filed as Exhibit 99.1 to Form 6-K (File No. 001-39957) filed on December 22, 2021).

“”
means “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act and all types of direct and indirect stock
pledges, forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis) whether such
transactions are made through U.S. or non-U.S. broker dealers or foreign regulated brokers (but shall not be deemed to include locating
and/or borrowing Common Shares).

“” means Baker McKenzie Switzerland AG, Holbeinstrasse 30, 8034 Zurich, Switzerland, Attn: Dr. Matthias Courvoisier, Esq.,
email: matthias.courvoisier@bakermckenzie.com.

“” shall have the meaning ascribed to such term in Section 4.1(d).

“”
means $1.65 per Preferred Share.

“”
means, as to each Purchaser, the aggregate cash amount to be paid for the Securities purchased hereunder at each Closing as specified
below such Purchaser’s name on the signature page of this Agreement.

“